Reimbursement Headwinds and Tailwinds: Reading the 2025–2026 Policy Map

Reimbursement is the gravitational field every healthcare business operates within, and it is rarely a simple story of better or worse. The 2025 to 2026 environment is a genuine mix: pressure in some places, support in others, and a great deal of variation by service line and payer. The useful exercise is not to forecast a single direction but to map where the headwinds and tailwinds sit, and to understand which businesses are built to navigate them.

The three-payer reality

Any serious discussion of reimbursement starts with payer mix. Government programs and commercial insurers behave very differently, and a provider business is shaped profoundly by where its revenue comes from. Medicare offers scale and predictability but tends to update rates conservatively, often below the pace of cost growth. Medicaid generally reimburses at the lowest levels and varies enormously by state, which makes geographic exposure a meaningful underwriting question. Commercial payers typically pay the most, but rates are negotiated, and leverage in those negotiations depends heavily on a provider scale and market position.

The practical implication is that two businesses with identical clinical operations can have very different financial profiles based purely on payer mix. We pay close attention to this, because a heavily government-weighted book carries different risk and margin characteristics than a commercially weighted one, and neither is inherently better in isolation. What matters is whether the mix is stable, defensible, and appropriately priced into the business.

Where the headwinds sit

The clearest headwinds are on the government side. Physician fee schedules have faced repeated pressure, and updates to government rates have generally trailed underlying cost inflation. For practices and facilities heavily dependent on these rates, that gap compounds into real margin erosion over time. Site-of-care policies that steer volume to lower-cost settings, while broadly sensible, also redistribute revenue away from higher-cost providers.

Layered on top is a continued push toward value-based and risk-bearing arrangements. For well-prepared organizations with the data, scale, and care-management capabilities to manage risk, these models can be a source of upside. For those without that infrastructure, taking on risk can be a fast way to convert a stable business into a volatile one. The direction of travel toward value-based care is real, but it is a tailwind for the prepared and a hazard for the unprepared.

Where the tailwinds sit

The tailwinds are quieter but meaningful. The broad expansion of procedures approved for ambulatory and outpatient settings supports providers positioned in those lower-cost sites. Demographic-driven volume growth provides a durable base of demand that lifts utilization across most service lines regardless of rate dynamics. And in segments where supply of providers is genuinely scarce relative to demand, providers retain real pricing and contracting leverage.

Specialty matters here too. Service lines tied to aging and chronic disease management generally enjoy a more supportive demand and reimbursement backdrop than those exposed to commoditization or aggressive site-of-care redirection. Reading the policy map well means matching a business specialty and setting to where the supports actually are.

Building businesses that can absorb the swings

Given all this, the most resilient providers share a few traits. They have diversified payer exposure rather than dangerous concentration in any single program. They invest in revenue cycle and contracting capability, because in a tight-margin environment, getting paid accurately and on time is itself a source of value. And they pursue the scale needed to negotiate from a position of strength rather than accept whatever rates are offered.

Our perspective is that reimbursement risk is best managed through preparation rather than prediction. We do not assume rates will move in our favor; we look for businesses that remain healthy across a range of plausible reimbursement outcomes, with the operational sophistication to capture upside from value-based models without betting the company on them. In a landscape this mixed, durability comes from diversification, contracting discipline, and a clear-eyed view of where a given business sits on the policy map, not from hoping the headwinds pass.